Clik here to view.
MassDevice.com +5 | The top 5 medtech stories for May 18, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
EuroPCR 2016 Roundup: TAVR innovations, FFR systems in the spotlight
St. Jude Medical (NYSE:STJ) announced it won CE Mark approval in the European Union for its PressureWire X Guidewire fractional flow reserve measurement system and is launching the product in Europe....
View ArticleClik here to view.
Presbia touts 6-month data for Flexivue microlens
Presbia (NSDQ:LENS) today reported interim data from a U.S. pivotal trial of its Flexivue microlens, touting an average gain of 5 lines of uncorrected near visual acuity and 99% maintenance of...
View ArticleClik here to view.
Siemens picks up German cancer diag company Neo New Oncology AG
Siemens (NYSE:SI) said yesterday it picked up German cancer genome diagnostic company Neo New Oncology AG for an undisclosed amount. The company said the purchase will give the company an “entry point”...
View ArticleClik here to view.
Partnerships and the pursuit of innovation at large and small companies
Anne Sissel, managing director of Baxter Ventures and Adam Berman, CEO of TVA Medical, Inc. shared their perspectives on topics related to innovation and partnership between large, commercial...
View ArticleClik here to view.
EuroPCR 2016: Study casts doubt on long-term TAVR durability
Study results released this week at the annual EuroPCR conference in Paris indicated that half of transcatheter aortic valve replacements had signs of degeneration within 10 years. The study looked at...
View ArticleClik here to view.
Medtronic: Infuse data delay was inadvertent
Medtronic (NYSE:MDT) reportedly said this week that its years-long delay in releasing adverse event data for its controversial Infuse bone-growth protein was inadvertent. The Minneapolis Star Tribune...
View ArticleClik here to view.
FDA approves Boston Scientific’s Precision Montage MRI-safe spinal cord...
Boston Scientific (NYSE:BSX) said it won FDA approval for its Precision Montage MRI-safe spinal cord stimulator for chronic pain and plans to launch the device tomorrow. The Precision Montage MRI SCS...
View ArticleClik here to view.
Philips inks $36m patient monitoring deal with Medical University of South...
Royal Philips (NYSE:PHG) said it inked an 8-year, $36 million deal with Medical University of South Carolina Health for its patient monitoring technology and services. The deal calls for the Dutch...
View ArticleClik here to view.
Nikkiso enters U.S. dialysis market with DBB-06 device
Nikkiso (TYO:6376) said the medical division of its Nikkiso America business entered the U.S. hemodialysis market with its DBB-06 system, after winning 510(k) clearance from the FDA in March....
View ArticleClik here to view.
Pulse Biosciences pounds out $20m with IPO
Pulse Biosciences raised $20 million in an initial public offering this week after floating 5 million shares at $4 apiece, for a fully diluted valuation of $51 million. Burlingame, Calif.-based Pulse...
View ArticleClik here to view.
Medtronic launches new cervical spine platform in the U.S.
Medtronic (NYSE:MDT) said today that it launched its Spine Essentials platform for cervical spine fusions. The offering is aimed at increasing the efficiency of the most common 1- and 2-level fusion...
View ArticleClik here to view.
B. Braun pays nearly $8m to settle contaminated saline case
B. Braun Medical agreed to pay $7.8 million and agreed to the facts in a non-prosecution agreement to avoid criminal charges that it sold contaminated saline syringes. Bethlehem, Pa.- and Melsungen,...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for May 19, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Jury awards Edwards Lifesciences $70m in CardiAQ Valve spat with Neovasc
A federal jury in Massachusetts yesterday awarded $70 million to Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve Technologies in a patent infringement lawsuit after finding that Neovasc...
View ArticleClik here to view.
Endo’s AMS claims pelvic mesh plaintiffs scammed into needless explantation...
Endo International (NSDQ:ENDP) subsidiary American Medical Systems Holdings repoortedly accused “a pyramid of businessmen, doctors and lawyers” of convincing women to undergo unnecessary surgeries to...
View ArticleClik here to view.
Johnson & Johnson’s robotics unit Verb Surgical aims for end-of-year unveiling
Johnson & Johnson (NYSE:JNJ) expects its Verb Surgical robot-assisted surgery business to move from concept to product design by the end of the year, company officials said this week as they...
View ArticleClik here to view.
Report: Medical device recalls hit 3-year low in Q1
Medical device recalls fell to their lowest point since 2013 during the 1st quarter, according to a report from Stericycle‘s (NSDQ:SRCL) ExpertSolutions business. Both the number of recalled units and...
View ArticleClik here to view.
Skyline Medical CEO Kornberg steps down, Schwartz takes over as interim |...
Skyline Medical CEO Kornberg steps down, Schwartz takes over as interim chief exec Skyline Medical said earlier this month that prez and CEO Joshua Kornberg was stepped away from his roles at the...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for May 20, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View Article